Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00319072 · ClinicalTrials.gov registry record · Phase 2

Hormone Replacement Therapy (HRT) Website Tool

A Phase 2 study, sponsored by National Institute on Aging (NIA).

Completed
Registry status
Phase 2
Development phase
280
Enrollment target

NCT00319072: Completed Phase 2 study, sponsored by National Institute on Aging (NIA).

NCT00319072 is a Phase 2 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 280 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (111% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00319072, a Phase 2 study, has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
Phase 2
Development phase
280 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate a prototype web-based module for patients to generate appropriate and focused health information along with a customized set of questions to take to their health care provider for discussion on hormone replacement therapy.

Interventions

  • BEHAVIORAL TalkToYourDoc(sm) hormone therapy module

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2004-03
Est. Completion 2005-12
Phase Phase 2
National Institute on Aging (NIA)

131 total trials

What the finished NCT00319072 record still lists

NCT00319072 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (111% higher).

The record links to 0 conditions, and to 1 intervention - of which TalkToYourDoc(sm) hormone therapy module is the first listed.

NCT00319072 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00319072 about?

NCT00319072 is a clinical study titled "Hormone Replacement Therapy (HRT) Website Tool". The purpose of this study is to evaluate a prototype web-based module for patients to generate appropriate and focused health information along with a customized set of questions to take to their health care provider for discussion on hormone replacement therapy.

What is the current status of trial NCT00319072?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 280 participants. The study started on 2004-03. Estimated completion is 2005-12.

What interventions are being tested in trial NCT00319072?

The interventions under investigation include: TalkToYourDoc(sm) hormone therapy module (BEHAVIORAL).

Who is sponsoring clinical trial NCT00319072?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00319072's enrollment target sits among peer trials

280 196th of 2000 higher than 1,800 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04084730 · 280 participants · Phase 2

    Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

  • NCT04518657 · 280 participants · NA

    Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis

  • NCT04634916 · 280 participants · NA

    Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

  • NCT04829617 · 280 participants · NA

    Promoting Well-being and Health in Heart Failure

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00319072, the US trial registry maintained by the National Library of Medicine. NCT00319072 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.